Abstract:Diabetes mellitus (DM) has become a vital societal problem as epidemiological studies demonstrate the increasing incidence of type 1 and type 2 diabetes. Lesions observed in the retina in the course of diabetes, referred to as diabetic retinopathy (DR), are caused by vascular abnormalities and are ischemic in nature. Vascular lesions in diabetes pertain to small vessels (microangiopathy) and involve precapillary arterioles, capillaries and small veins. Pericyte loss, thickening of the basement membrane, and damage and proliferation of endothelial cells are observed. Endothelial cells (monolayer squamous epithelium) form the smooth internal vascular lining indispensable for normal blood flow. Breaking its continuity initiates blood coagulation at that site. The endothelium controls the process of exchange of chemical substances (nutritional, regulatory, waste products) between blood and the retina, and blood cell passing through the vascular wall. Endothelial cells produce biologically active substances involved in blood coagulation, regulating vascular wall tension and stimulating neoangiogenesis. On the other hand, recent studies have demonstrated that diabetic retinopathy may be not only a microvascular disease, but is a result of neuroretinal degeneration. Neuroretinal degeneration appears structurally, as neural apoptosis of amacrine and Muller cells, reactive gliosis, ganglion cell layer/inner plexiform (GCL) thickness, retinal thickness, and retinal nerve fiber layer thickness, and a reduction of the neuroretinal rim in minimum rim width (MRW) and functionally as an abnormal electroretinogram (ERG), dark adaptation, contrast sensitivity, color vision, and microperimetric test. The findings in early stages of diabetic retinopathy may precede microvascular changes of this disease. Furthermore, the article’s objective is to characterize the factors and mechanisms conducive to microvascular changes and neuroretinal apoptosis in diabetic retinopathy. Only when all the measures preventing vascular dysfunction are determined will the risk of complications in the course of diabetes be minimized.

The retina-brain axis and diabetic retinopathy

Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy

Diabetic retinopathy: current understanding, mechanisms, and treatment strategies

Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus

Current understanding of the molecular and cellular pathology of diabetic retinopathy

Photoreceptor responses to light in the pathogenesis of diabetic retinopathy

Diabetes mellitus associated neurovascular lesions in the retina and brain: A review

The pathophysiological mechanisms underlying diabetic retinopathy

Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients

The innate immune system in diabetic retinopathy

Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration

Retinal Cell Damage in Diabetic Retinopathy

Perspectives of diabetic retinopathy—challenges and opportunities

Diabetic retinopathy: Involved cells, biomarkers, and treatments

Glucose transport, transporters and metabolism in diabetic retinopathy

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

An overview of the pathogenesis of diabetic retinopathy

Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy

Resilience to diabetic retinopathy

Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets